Radonbalneology Prof. Dr.med. habil. Dr.rer.nat. Helmut G. Pratzel President of the International Society of Medical Hydrology and Climatology (I.S.M.H.)

Slides:



Advertisements
Similar presentations
Appraisal of an RCT using a critical appraisal checklist
Advertisements

Linoxsmart S DX Master Study
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia N Engl J Med Mar 11;362(10): Paul W. Ladenson, M.D., Jens D.
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized control trial (BMJ. 2010;341:c5462)
Design of Dose Response Clinical Trials
Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.
1 Superior Safety in Noninferiority Trials David R. Bristol To appear in Biometrical Journal, 2005.
Chapter 6: Community Health Indicators. 56 Chartbook 2000 Population The population of the United States is expected to grow at a relatively constant.
MULTIPLICATION EQUATIONS 1. SOLVE FOR X 3. WHAT EVER YOU DO TO ONE SIDE YOU HAVE TO DO TO THE OTHER 2. DIVIDE BY THE NUMBER IN FRONT OF THE VARIABLE.
A randomised, controlled trial to compare prednisolone with doxycycline.
Results of the Prospective, Randomized, Multicenter FDA Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Versus Circumferential.
RANDOMIZED CONTROLLED TRIAL
Presented by: CAPT Christine Chamberlain, PharmD, BCPS, CDE Multidisciplinary Approach to Inpatient Blood Glucose Management.
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know!
Cardiac Insufficiency Bisoprolol Study (CIBIS III) Trial
Phase II/III Design: Case Study
Presentation of BE data in a product dossier Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
ROCKET-AF Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
P. S. KUNDHAL ET AL. JAMA November, 2013 Moderator – Dr Vineet Ahuja
PROCESS vs. WA State SCS Study A Comparison of Study Design, Patient Population, and Outcomes August 29,2007.
Clinical Trial Results. org Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease Renzo Zanettini, M.D.; Angelo Antonini, M.D.;
The Effect of Peloid Application in Out-patient Setting on Knee Osteoarthritis Results of a Pilot Study E Odabaşı, R Tekin, H Erdem, İ.Şimşek, M Turan.
CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
Analysis of the ADVANCE Trial Sapna N. Patel UCSF Pharm. D. Candidate 2008 Preceptor Dr. Craig S. Stern March 28, 2008.
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
A randomized controlled trial of citalopram on migraine frequency Satnam S. Nijjar, M.D. Department of Neurology, Johns Hopkins School of Medicine.
The organisation of research on thermalism in Europe – The situation in eastern Europe and Turkey M. Zeki KARAGÜLLE Department of Medical Ecology and Hydroclimatology.
CAPRIE: Clopidogrel versus Aspirin in Patients at risk of Ischemic Events Purpose To assess the relative efficacy of the antiplatelet drugs clopidogrel.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
ARTIFICIAL DISC VERSUS FUSION A prospective randomised study with 2-year follow-up on 99 patients.
Eligibility: The deciding factor. Eligibility Criteria Select subjects that are as homogenous as possible Select subjects that are as homogenous as possible.
A randomized, double-blind study on MD-knee versus HA in patients affected by knee OA: preliminary data from the JOINT study Umberto Massafra Dep of Rheumatology,
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
Introduction to Clinical Protocol
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Our Experiences With Natural Natural Products As Potential Therapeutic Agents : Towards Safer & Cost Effective Therapy Dr. Mrs.Chanda Kulkarni. MBBS; MD;
Yesterday, today, and tomorrow
Is balneotherapy more effective than hydrotherapy? M. Zeki Karagülle IV. TURKISH - HUNGARIAN BALNEOLOGICAL MEETING January 2006 Balçova, Turkey.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP NIAID/DAIDS Dione Washington, M.S. -- ProPEP Sudha Srinivasan, Ph.D.-- TRP Tanisha.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Balneotherapy in Rheumatologic Conditions Dr. Deniz EVCİK Kocatepe University,Dep. of PRM,Afyon- TURKEY.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
1 Statistical Review Dr. Shan Sun-Mitchell. 2 ENT Primary endpoint: Time to treatment failure by day 50 Placebo BDP Patients randomized Number.
BÁLINT G, ÁDÁM A, RATKÓ I, SOMOS É, POÓR L, BÁLINT P, TEFNER I, BENDER T. Budapest, Hungary DOUBLE BLIND STUDY ABOUT THE EFFECTIVITY OF THE THERMAL MINERAL.
EFFICACY OF SPA THERAPY IN RHEUMATOID ARTHRITIS-A RANDOMISED CONTROLLED CLINICAL STUDY Mine Karagülle Department of Medical Ecology and Hydroclimatology.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Clinical trial The Way We Make Progress Against Disease Prof. Ashry Gad Mohamed Prof. of Epidemiology College of Medicine & KKUH.
A Randomised, Controlled Trial of Acetaminophen, Ibuprofen, and Codeine for Acute Pain relief in Children with Musculoskeletal Trauma Clark et al, Paediatrics.
How To Design a Clinical Trial
Dr. ANJU PADMALAYAN PG CO AUTHORS: Prof.& HOD Dr.I.CHANDRASEKARAN MD, DA Prof.Dr.GANESH PRABHU MD, DA., Asst.Prof.Dr. SIVAPRASATH MD., INSTITUTE OF ANAESTHESIOLOGY.
PTP 661 EVIDENCE ABOUT INTERVENTIONS CRITICALLY APPRAISE THE QUALITY AND APPLICABILITY OF AN INTERVENTION RESEARCH STUDY Min Huang, PT, PhD, NCS.
OFEV ® (nintedanib) TOMORROW trial results Last updated These slides are provided by Boehringer Ingelheim for medical to medical education only.
Efectivness of Spa Therapy in Severe Knee Osteoarthritis; Randomize Controlled Trial Mine Karagülle,MD Istanbul, Turkey.
Zometa for Prostate Cancer Bone Metastases Protocol 039 Amna Ibrahim, M.D. Oncology Drug Products FDA.
Efficacy of Colchicine When Added to Traditional Anti- Inflammatory Therapy in the Treatment of Pericarditis Efficacy of Colchicine When Added to Traditional.
GCP (GOOD CLINICAL PRACTISE)
How To Design a Clinical Trial
Assign membership into BFO/OBI branches
The Anglo Scandinavian Cardiac Outcomes Trial
Nat. Rev. Nephrol. doi: /nrneph
بسم الله الرحمن الرحیم.
Ethical Principles of Research
Unit 4 - Immunology and Public Health
ASAS 20/40 response rates, and mean change from baseline in BASDAI through week 156* of treatment. *For patients who discontinued, the end of treatment.
Clinical Trials Oct. 6, Lyon France
How Should We Select and Define Trial Estimands
Presentation transcript:

Radonbalneology Prof. Dr.med. habil. Dr.rer.nat. Helmut G. Pratzel President of the International Society of Medical Hydrology and Climatology (I.S.M.H.) Prof. Dr.med. habil. Dr.rer.nat. Helmut G. Pratzel President of the International Society of Medical Hydrology and Climatology (I.S.M.H.)

Quality limits for medical bath waters Chemical effects can be used in bath tubs if –no disinfection –Concentration in tub is H 2 S > 10 mg/l Radon > 1 kBq/l CO 2 > 1 g/l Brine g/l Physical effects can be used in pools if –water is disinfected –temperature >30 °C Which elements in spring waters are effective in bath therapy?

Radon Units 1 Mache Unit = 3,64 x Ci/l 1 Ci = 3,7 x Bq 1 Mache Unit = 13,468 Bq/l

Spas using Radonwater

Russian Radon Spas Belochurika (Altai) 4-16 nCi/l Dzchey-Ogus, Issyk-Kul (Kirgisia) nCi/l Nowosibirsk (Sibiria) nCi/l Pjatigorsk (North Kaukasus) nCi/l Chmelnik (Ukraine) 2-97 nCi/l Zhal-Tubo (Georgia) 2,5-33 nCi/l 250 Sanatoria with artificial Radon

Indications Radon-Water in bath tubs and Radon-Gas-baths or Radon-mines Ankylosing spondylitis Degenerative joint disease Spondylarthrosis Myofascial soft tissue syndrome Ovarian hypofunction Allergic bronchial Asthma

Clinical Trial Protocol by the Guidelines for Good Clinical Practice (GCP) of the European Community  Trial objectives and purpose  Trial design  Randomisation, Blinding  Selection and withdrawal of subjects  inclusion and exclusion criteria  Treatment of subjects and control medication  Assessment of efficacy  Assessment of safety  Control of side effects and interactions  Control of Compliance  Statistics  Direct Access to Source Data/Documents  Quality control and Quality Assurance Procedures  Ethics

Primary Efficacy Variable Only validated parameters should be used. Only one efficacy parameter is to defined. Endpoints used to determine efficacy should be clearly specified. Multiple parameters should be assembled to one score parameter. An efficacy threshold is to defined.

Controlled Double-Blind Trials on Radon  Pratzel, Legler, Aurand, Baumann, Franke: Phys Rehab Kur Med 3 (1993)  Lind-Albrecht 1994  Heisig, Klein, Pratzel 1997  Reiner, Vulpe, Pratzel 1998  Skorepa, Klein, Pratzel 1999  Keil, Klein, Pratzel (not finished)  Pratzel, Legler, Aurand, Baumann, Franke: Phys Rehab Kur Med 3 (1993)  Lind-Albrecht 1994  Heisig, Klein, Pratzel 1997  Reiner, Vulpe, Pratzel 1998  Skorepa, Klein, Pratzel 1999  Keil, Klein, Pratzel (not finished)

Pressure Pain Threshold Test areas 1. M. levator scapulae 2. M. supraspinatus 3. M. teres minor 4. M. deltoideus 5. M. glutaeus maximus 6. M. glutaeus medius 7. M. bizeps femoris 8. M. semimembranosus

Double-blind-control equipment Electronic control with bar-code- reader Technical roomBathroom Tap-water line Radon-water line Bath-tub Magnetic valves Bar-code- reader

The Barcode-Reader

Pratzel, Legler, Baumann: Analgesic Efficacy of Radon baths in case of spondylosis with cervical pain Subject: patients y Verum: Radon baths 3000 Bq/l Control: Water baths Treatment: 9 baths 36 °C during 3 weeks Design: ambulant, massage and gymnastics Follow-up: 2 and 4 months Result: difference in follow-up period p<0,001 Subject: patients y Verum: Radon baths 3000 Bq/l Control: Water baths Treatment: 9 baths 36 °C during 3 weeks Design: ambulant, massage and gymnastics Follow-up: 2 and 4 months Result: difference in follow-up period p<0,001

Pressure pain threshold by Radon baths series Ende der Behandlung Period of inspection kg/cm 2 After 1 week After 2 weeks After 3 weeks After 2 month After 4 month 2,0 2,2 2,4 2,6 2,8 3,0 RADON WATER TAP WATER End of Treatment

Pressure Pain Threshold 3000 Bq/L Rn Schlema kg/qcm Control Radon p=0,0007p=0,028 Period of evaluation after 1st week after 2nd week after 3rd week Follow up after 2 months Follow up after 4 months

Pressure Pain Threshold and subjective feeling of pain VAS before after 1 week after 2 weeks after 3 weeks after 4 months PPT general pressure pain threshold VAS subjective pain feeling 3 baths 3 kBq/L Follow-up period after 2 months PPT

Subjective feeling of pain WaterRadon

Pain on movement Water Radon

Pain at rest WaterRadon

Heisig: Analgetic effect of Radon baths in degenerative joint disease and spondylarthrosis Subject: patients y Verum: Radon baths 800 Bq/l Control: Water baths Treatment: 8 baths 36 °C during 3 weeks Design: ambulant, mono-therapy Follow-up: 2 and 4 months Result: difference in follow-up period p<0,05 Subject: patients y Verum: Radon baths 800 Bq/l Control: Water baths Treatment: 8 baths 36 °C during 3 weeks Design: ambulant, mono-therapy Follow-up: 2 and 4 months Result: difference in follow-up period p<0,05

Change of Pressure Pain Threshold Bad Steben kg/qcm p=0,0141 Control Radon Period of evaluation after 1st week after 2nd week after 3rd week Follow up after 2 months Follow up after 4 months

Pressure Pain Threshold (mean and max) MAX beforeafter 1 weekafter 2 weeksafter 3 weeksafter 2 months after 4 months PPT general pressure pain threshold MAX maximum pressure pain threshold 3 baths 0,8 kBq/L PPT Follow-up period

Pressure Pain Threshold and Subjective feeling of pain VAS before after 1 week after 2 weeks after 3 weeks after 2 months after 4 months PPT PPT general pressure pain threshold VAS subjective pain feeling 3 baths 0,8 kBq/L Follow-up period PPT

Skorepa: Effect of CO 2 in Radon baths treatment in degenerative joint disease and spondylarthrosis Subject: patients y Verum: Radon 400 Bq/l and CO 2 1 kg/l Control: Radon baths 800 Bq/l Treatment: 8 baths 36 °C during 3 weeks Design: ambulant, mono-therapy Result: no difference: CO 2 increase radon effect

Pressure Pain Threshold Bad Steben 1997 before after 1 week after 2 weeks after 3 weeks after 4 months Follow-up period after 2 months

Subjective Feeling of Pain Bad Steben 1997 before after 1 week after 2 weeks after 3 weeks after 4 months Follow-up period after 2 months

Maximum Pressure Pain Threshold Bad Steben 1997 before after 1 week after 2 weeks after 3 weeks after 4 months Follow-up period after 2 months

Franke, Reiner, Pratzel, Franke, Resch: Long-term efficacy of radon spa therapy in rheumatoid arthritis – a randomized, sham- controlled study and follow-up. Rheumatology 2000:39: Subject: RA patients <75 y Verum: natural radon 1,3 kBq/l and CO 2 1,6 kg/l Control: artificial CO 2 1,6 kg/l Application: 15 baths 35 °C during 4 weeks Follow up: 3 and 6 month after end of treatment Result: relevant difference in follow-up period

Subjective pain feeling Rheumatoide Arthritis (Radon trial Bad Brambach 1997) 1st value CO 2 Radon + CO 2 mm VAS N = 30N = 30/27N = 28/30 Differences to 1st value and 95%-Confidence interval Improvement

Moving test by Keitel To bend the fingers Motility of hand joins and arms Stand up from lying Active straddle of legs from lying Stand up from a stool Standing on toes and heel Knee-crooking Standing on one foot Outside Rotation of the hit join Mobility of legs and feet Walking Climbing stairs

Moving Test by Keitel Rheumatoide Arthritis (Radon trial Bad Brambach 1997) Radon+CO 2 N = 30N = 28/30N = 30/29 Skt Differenzen zum Ausgangswert und 95%-Konfidenzintervall Improvement 1st value CO 2

Measurement of Patient Outcome – MOPO (AIMS –questionaire) Physical handicap and psychosocial Consequences by Rheumatoid Arthritis Mobility Physical activity Skill Activities at home Activities in daily life Social activities Pain Depression Anxiety Assessment included:

Measurement of Patient Outcome (MOPO) Rheumatoide Arthritis (Radon trial Bad Brambach 1997) Radon+CO 2 Differenzen zum Ausgangswert und 95%-Konfidenzintervall Skt N = 29/30 Improvement 1st value CO 2

Lind-Albrecht: Treatment of ankylosing spondylitis in radon mine Bad Kreuznach Subject: SA patients, randomized Verum: 10 x 1 hour radon mine Control: no mine Application: 4 weeks Follow up: 3, 6, 9, 12 month after end of treatment Result: relevant difference in follow-up period

Relat. Pain after Radon mine treatment Bad Kreuznach Spondylitis Ankylosans (Studie Lind-Albrecht)

Relat. NSAIDS-use after Radon mine treatment Bad Kreuznach Spondylitis Ankylosans (Studie Lind-Albrecht)

Meta- Analyse Forest-Plot treatmentcontrol

Die Permeabilität der Haut Resorption für Gase und Flüssigkeiten durch 2 m 2 Haut L/h ,1 0,01 N2N2 He Ar H 2 H2SH2S O2O2 CO 2 Rn mL/h n-Pentanol n-Butanol Wasser iso-Butanol Ethanol DMSO

0,0001 0,001 0,01 0, µl Lösung/cm 2 /h Cortison Corticosteron Indomethacine Salicylic acid Hydrocortison Heparin Acetylsalicylic acid DMSO Progesteron Testosteron Estron Methylsalicylat Jodide Sulfate Strontium Cobalt Silver Pertechnetate Arsenic Bromide Ferrum II Selenite Chromium III Ferrum III Cadmium Caesium Calcium Chloride Potassium Sodium Phenylmercuryborate Methanol Water H2SH2S Radon CO 2 Permeability of skin Skin clearance for solutions in water Water Ethanol Propanol Campher Camphen Heptanol Octanol

How Dosis can be calculated by Skin-Clearance? Dosis = Skin-Clearance x Area x Concentration x Time Dosis limit is the amount on the Skin Skin-Clearance is realized by optimal Penetration situation ( Bath, wet Skin, Okklusion Effect of temperature (Q 10. = 1,1-1,4) but skin temperature only low variable

Blood level and time of bathing Badedauer Fließgleichgewicht erreicht nicht erreicht

Calculation about Radon-kinetic Skin-Clearance = 200 µl/cm 2 h -1 Concentration in bath = 3 kBq/l Area of skin = 2 m 2 Absorption rate = 200 x 3 x 2/100 = 12 kBq/h Skin-Clearance = 200 µl/cm 2 h -1 Concentration in bath = 3 kBq/l Area of skin = 2 m 2 Absorption rate = 200 x 3 x 2/100 = 12 kBq/h Distribution volum = 20 l bei 80 kg KG Elimination constant = 20 h -1 Blood level in steady state= 12 kBq/h / (20 l x 20 h -1 ) = 0,030 kBq/l Blood level after 10 min-bath = 0,030 x (1-e -20 h-1 x 10 min ) = 0,029 kBq/l Concentration in bath water : Blood level = 100 : 1 Distribution volum = 20 l bei 80 kg KG Elimination constant = 20 h -1 Blood level in steady state= 12 kBq/h / (20 l x 20 h -1 ) = 0,030 kBq/l Blood level after 10 min-bath = 0,030 x (1-e -20 h-1 x 10 min ) = 0,029 kBq/l Concentration in bath water : Blood level = 100 : 1

Radon-222 Dissolution Polonium Bismutum Plumbum

The main effect of radon Radon and the dissolution products penetrate into the horny layer. Alpha-radiation from the horny layer is effective in the stratum spinosum. Dissolution products cannnot penetrate into the living tissue. Radon and the dissolution products penetrate into the horny layer. Alpha-radiation from the horny layer is effective in the stratum spinosum. Dissolution products cannnot penetrate into the living tissue.

Langerhans Cells of the skin

Effect of Alpha-Radiation on Langerhans Cells

Dosis by use of Radon-baths (Radon concentration 1,5 kBq/L; 37 °C) Dosis of skin Dosis of kidneys Dosis of other organs natürliche Dosisleistung Maximum Zeit in Stunden Bath period 20 minutes Risk by radon skin-dosis of ca. 1 mSv per cure treatment is lesser than risk by long use of medicaments..

Trial in radon treatment should be used in future research by the following disease assessments Rheumatoide A.HAQ BechterewBASFI Narrow spinal channelLSS-Inst. OsteoarthrosisWOMAC German translation by Sangha O et.al. Rheumatol 56: , 1997

BASFI for Ankylosing Spondylitis Ohne Hilfe und Hilfsmittel Socken und Strümpfe anziehen Ohne Hilfe von der Hüfte aus nach vorn beugen um einen Kugelschreiber vom Boden aufzuheben Ohne Hilfe etwas von einem Regal nehmen Von einem Wohnzimmerstuhl ohne Armlehne aufstehen ohne dabei die Hände oder eine andere Hilfe zu benutzen Ohne Hilfe vom Boden aufstehen, wenn Sie auf dem Rücken liegen German translation by Sangha O et.al. Rheumatol 56: , 1997

BASFI for Ankylosing Spondylitis Ohne Schmerzen 10 Minuten stehen ohne sich anzulehnen Ohne Benutzung eines Geländers oder Gehhilfen Treppenstufen steigen. 1 Fuß pro Stufe Über die Schulter schauen ohne dabei den Körper abzudrehen. Körperlich anstrengende Tätigkeiten verrichten (z.B. krankengymnastische Übungen, Gartenarbeit oder Sport) Zu Hause oder bei der Arbeit den ganzen Tag aktiv sein. German translation by Sangha O et.al. Rheumatol 56: , 1997

Literature of Radonbalneology Pratzel, Deetjen: Radon in der Kurortmedizin, I.S.M.H. Verlag 1997, ISBN Pratzel: Application of Pressure Algometry in Balneology for Evaluation of Physical Therapeutic Modalities and Drug Effects. Journal of Musculoskeletal Pain:1998:6: Deetjen, Falkenbach: Radon und Gesundheit, Peter Lang Verlag 1999, ISBN Franke, Reiner, Pratzel, Franke, Resch: Long-term efficacy of radon spa therapy in rheumatoid arthritis – a randomized, sham- controlled study and follow-up. Rheumatology 2000:39: Pratzel, Deetjen: Radon in der Kurortmedizin, I.S.M.H. Verlag 1997, ISBN Pratzel: Application of Pressure Algometry in Balneology for Evaluation of Physical Therapeutic Modalities and Drug Effects. Journal of Musculoskeletal Pain:1998:6: Deetjen, Falkenbach: Radon und Gesundheit, Peter Lang Verlag 1999, ISBN Franke, Reiner, Pratzel, Franke, Resch: Long-term efficacy of radon spa therapy in rheumatoid arthritis – a randomized, sham- controlled study and follow-up. Rheumatology 2000:39:

The following power point-files Perkutane Resorption und Balneologie (German) Kneipp-Therapie (German) Radonbalneology (English) Health Tourism and Medical Treatment - two parts in Health Resorts (English) Las nuevas investigaciones en termalismo y los nuevos retos medicos (Spanish) can be downloaded from the web side of the International Society of Medical Hydrology and Climatology:

End of Slides